Brief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
08/10/2026 02:01
BRIEF-Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module Oct 8 (Reuters) - Imricor Medical Systems, Inc IMR.AX:
FDA COMPLETES REVIEW OF IMRICOR'S THIRD PMA MODULE
NO DEFICIENCIES IDENTIFIED FOR VISION-MR ABLATION CATHETER 2.0
PREPARING RESPONSE TO FDA FOR MODULE 3 CLOSURE
Further company coverage: IMR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion